Merck & Company, Inc. (
) will begin trading ex-dividend on December 12, 2013. A cash
dividend payment of $0.44 per share is scheduled to be paid on
January 08, 2014. Shareholders who purchased MRK stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 2.33% increase over the prior quarter. At the current
stock price of $49.43, the dividend yield is 3.56%.
The previous trading day's last sale of MRK was $49.43,
representing a -1.96% decrease from the 52 week high of $50.42 and
a 23.51% increase over the 52 week low of $40.02.
MRK is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). MRK's current earnings per share, an indicator of a company's
profitability, is $1.66. Zacks Investment Research reports MRK's
forecasted earnings growth in 2013 as -8.46%, compared to an
industry average of -2.8%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to MRK through an Exchange
Traded Fund [ETF]?
The following ETF(s) have MRK as a top-10 holding:
- iShares U.S. Pharmaceutical ETF (
- First Trust Morningstar Dividend Leaders Index Fund (
- Select Sector SPDR Fund - Health Care (
- Vanguard Health Care ETF (
- iShares Dow Jones U.S. Health Care Index Fund (
The top-performing ETF of this group is IHE with an increase of
11.16% over the last 100 days. It also has the highest percent
weighting of MRK at 7.67%.